Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome

American Diabetes Association, 2012, Diagnosis and classification of diabetes mellitus, Diabetes Care, 35, S64, 10.2337/dc12-s064

Amed, 2016, Maturity-Onset Diabetes of the Young (MODY): Making the right diagnosis to optimize treatment, Can J Diabetes, 40, 449, 10.1016/j.jcjd.2016.03.002

De Franco, 2015, The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: An international cohort study, Lancet, 386, 957, 10.1016/S0140-6736(15)60098-8

Shields, 2015, Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature, BMJ Open, 5, e009088, 10.1136/bmjopen-2015-009088

Turner, 1997, UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group, Lancet, 350, 1288, 10.1016/S0140-6736(97)03062-6

Fatima, 2013, Type 1 and type 2 diabetes mellitus: Are they mutually exclusive?, Singapore Med J, 54, 396, 10.11622/smedj.2013141

Naylor, 2011, Who should have genetic testing for maturity-onset diabetes of the young?, Clin Endocrinol (Oxf), 75, 422, 10.1111/j.1365-2265.2011.04049.x

Patel, 2010, Diabetes mellitus: Diagnosis and screening, Am Fam Physician, 81, 863

Unger, 1985, Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes, Diabetologia, 28, 119, 10.1007/BF00273856

Jones, 2013, The clinical utility of C-peptide measurement in the care of patients with diabetes, Diabet Med, 30, 803, 10.1111/dme.12159

Redondo, 2013, Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis, Pediatr Diabetes, 14, 333, 10.1111/pedi.12022

Maldonado, 2003, Ketosis-prone diabetes: Dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes, J Clin Endocrinol Metab, 88, 5090, 10.1210/jc.2003-030180

Oram, 2016, A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults, Diabetes Care, 39, 337, 10.2337/dc15-1111

Sacks, 2011, Executive summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus, Clin Chem, 57, 793, 10.1373/clinchem.2011.163634

Nakagami, 2017, Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy, Diabetes Res Clin Pract, 124, 20, 10.1016/j.diabres.2016.12.013

McCance, 1994, Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes, BMJ, 308, 1323, 10.1136/bmj.308.6940.1323

Engelgau, 1997, Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited, Diabetes Care, 20, 785, 10.2337/diacare.20.5.785

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183

The International Expert Committee, 2009, International expert committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033

Sabanayagam, 2015, Diagnosis of diabetes mellitus using HbA1c in Asians: Relationship between HbA1c and retinopathy in a multiethnic Asian population, J Clin Endocrinol Metab, 100, 689, 10.1210/jc.2014-2498

Ito, 2013, Evidence for diabetes mellitus criteria in 2010 using HbA1c, Diabetol Int, 4, 9, 10.1007/s13340-012-0086-7

Kowall, 2013, HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?, Diabetes Metab Syndr Obes, 6, 477, 10.2147/DMSO.S39093

Sarwar, 2010, Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review, PLoS Med, 7, e1000278, 10.1371/journal.pmed.1000278

Selvin, 2010, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults, N Engl J Med, 362, 800, 10.1056/NEJMoa0908359

International Diabetes Federation, 2011, Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus, Diabetes Res Clin Pract, 93, 299, 10.1016/j.diabres.2011.03.012

Nielsen, 2014, Changing from glucose to HbA1c for diabetes diagnosis: Predictive values of one test and importance of analytical bias and imprecision, Clin Chem Lab Med, 52, 1069, 10.1515/cclm-2013-0337

Rosella, 2015, Prevalence of prediabetes and undiagnosed diabetes in Canada (2007–2011) according to fasting plasma glucose and HbA1c screening criteria, Diabetes Care, 38, 1299, 10.2337/dc14-2474

Karnchanasorn, 2016, Comparison of the current diagnostic criterion of HbA1c with fasting and 2-hour plasma glucose concentration, J Diabetes Res, 2016, 6195494, 10.1155/2016/6195494

Gallagher, 2009, Review of hemoglobin A(1c) in the management of diabetes, J Diabetes, 1, 9, 10.1111/j.1753-0407.2009.00009.x

Yang, 2013, HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves' hyperthyroidism, Diabetes Res Clin Pract, 101, 28, 10.1016/j.diabres.2013.04.008

Son, 2013, Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects, Diabetes Metab J, 37, 343, 10.4093/dmj.2013.37.5.343

Attard, 2015, Implications of iron deficiency/anemia on the classification of diabetes using HbA1c, Nutr Diabetes, 5, e166, 10.1038/nutd.2015.16

Cavagnolli, 2015, Factors affecting A1C in non-diabetic individuals: Review and meta-analysis, Clin Chim Acta, 445, 107, 10.1016/j.cca.2015.03.024

Bazo-Alvarez, 2017, Glycated haemoglobin (HbA1c) and fasting plasma glucose relationships in sea-level and high-altitude settings, Diabet Med, 34, 804, 10.1111/dme.13335

Herman, 2007, Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program, Diabetes Care, 30, 2453, 10.2337/dc06-2003

Ziemer, 2010, Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies, Ann Intern Med, 152, 770, 10.7326/0003-4819-152-12-201006150-00004

Carson, 2016, Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes, BMJ Open Diabetes Res Care, 4, e000213, 10.1136/bmjdrc-2016-000213

Cavagnolli, 2017, Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis, PLoS ONE, 12, e0171315, 10.1371/journal.pone.0171315

Tsugawa, 2012, Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study, Ann Intern Med, 157, 153, 10.7326/0003-4819-157-3-201208070-00004

Davidson, 2010, Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: Implications for the diagnosis of diabetes, Diabetes Res Clin Pract, 87, 415, 10.1016/j.diabres.2009.12.013

Pani, 2008, Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring study and the National Health and Nutrition Examination Survey 2001–2004, Diabetes Care, 31, 1991, 10.2337/dc08-0577

Moran, 2010, Clinical care guidelines for cystic fibrosis–related diabetes. A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, 33, 2697, 10.2337/dc10-1768

Sacks, 2011, A1C versus glucose testing: A comparison, Diabetes Care, 34, 518, 10.2337/dc10-1546

Christophi, 2013, Confirming glycemic status in the Diabetes Prevention Program: Implications for diagnosing diabetes in high risk adults, J Diabetes Complications, 27, 150, 10.1016/j.jdiacomp.2012.09.012

Santaguida, 2005

Huang, 2016, Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis, BMJ, 355, i5953, 10.1136/bmj.i5953

Warren, 2016, Comparative prognostic performance of definitions of prediabetes: A prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study, Lancet Diabetes Endocrinol, 5, 34, 10.1016/S2213-8587(16)30321-7

Shaw, 2006, Point: Impaired fasting glucose: The case for the new American Diabetes Association criterion, Diabetes Care, 29, 1170, 10.2337/dc06-0013

Forouhi, 2006, The threshold for diagnosing impaired fasting glucose: A position statement by the European Diabetes Epidemiology Group, Diabetologia, 49, 822, 10.1007/s00125-006-0189-4

Zhang, 2010, A1C level and future risk of diabetes: A systematic review, Diabetes Care, 33, 1665, 10.2337/dc09-1939

Heianza, 2012, Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: The Toranomon Hospital Health Management Center Study 4 (TOPICS 4), Diabet Med, 29, e279, 10.1111/j.1464-5491.2012.03686.x

Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595

Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644

Colagiuri, 2011, Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes, Diabetes Care, 34, 145, 10.2337/dc10-1206

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097